{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:46:37Z","timestamp":1789159597916,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10096-020-04123-z","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:03:07Z","timestamp":1609977787000},"page":"1149-1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Performance of VITEK 2, E-test, Kirby\u2013Bauer disk diffusion, and modified Kirby\u2013Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter study in China"],"prefix":"10.1007","volume":"40","author":[{"given":"Dandan","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fupin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"issue":"suppl_1","key":"4123_CR1","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","volume":"215","author":"LK Logan","year":"2017","unstructured":"Logan LK, Weinstein RA (2017) The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 215(suppl_1):S28\u2013S36","journal-title":"J Infect Dis"},{"issue":"8","key":"4123_CR2","doi-asserted-by":"publisher","first-page":"e9961","DOI":"10.1097\/MD.0000000000009961","volume":"97","author":"TT Geng","year":"2018","unstructured":"Geng TT, Xu X, Huang M (2018) High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a retrospective cohort study. Medicine (Baltimore) 97(8):e9961","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"4123_CR3","doi-asserted-by":"publisher","first-page":"e3126","DOI":"10.1097\/MD.0000000000003126","volume":"95","author":"W Ni","year":"2016","unstructured":"Ni W, Han Y, Liu J et al (2016) Tigecycline treatment for carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. Medicine (Baltimore) 95(11):e3126","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"4123_CR4","first-page":"503","volume":"37","author":"S Grandesso","year":"2014","unstructured":"Grandesso S, Sapino B, Amici G et al (2014) Are E-test and Vitek2 good choices for tigecycline susceptibility testing when comparing broth microdilution for MDR and XDR Acinetobacter baumannii? New Microbiol 37(4):503\u2013508","journal-title":"New Microbiol"},{"issue":"8","key":"4123_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1099\/jmm.0.000281","volume":"65","author":"EA Idelevich","year":"2016","unstructured":"Idelevich EA, B\u00fcsing M, Mischnik A et al (2016) False non-susceptible results of tigecycline susceptibility testing against Enterobacteriaceae by an automated system: a multicentre study. J Med Microbiol 65(8):877\u2013881","journal-title":"J Med Microbiol"},{"issue":"10","key":"4123_CR6","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1128\/AAC.01406-06","volume":"51","author":"JR Lo-Ten-Foe","year":"2007","unstructured":"Lo-Ten-Foe JR, de Smet AM, Diederen BM et al (2007) Comparative evaluation of the VITEK 2, disk diffusion, E-test, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including hetero resistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 51(10):3726\u20133730","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4123_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1128\/JCM.01588-06","volume":"45","author":"RN Jones","year":"2007","unstructured":"Jones RN, Ferraro MJ, Reller LB et al (2007) Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 45(1):227\u2013230","journal-title":"J Clin Microbiol"},{"key":"4123_CR8","unstructured":"Clinical and Laboratory Standards Institute (2019) Performance standards for antimicrobial susceptibility testing. 29th edn. CLSI supplement M100. Wayne, America"},{"issue":"2","key":"4123_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jgar.2015.02.004","volume":"3","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhao C, Chen H et al (2015) Comparative evaluation of tigecycline susceptibility testing methods for Acinetobacter baumannii and Enterobacteriaceae. J Glob Antimicrob Resist 3(2):75\u201379","journal-title":"J Glob Antimicrob Resist"},{"key":"4123_CR10","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.1128\/AAC.03808-14","volume":"58","author":"ZK Sheng","year":"2014","unstructured":"Sheng ZK, Hu F, Wang W et al (2014) Mechanisms of tigecycline resistance among Klebsiella pneumoniae clinical isolates. Antimicrob Agents Chemother 58:6982\u20136985","journal-title":"Antimicrob Agents Chemother"},{"key":"4123_CR11","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1128\/AAC.01803-13","volume":"58","author":"L Villa","year":"2014","unstructured":"Villa L, Feudi C, Fortini D, Garcia-Fernandez A, Carattoli A (2014) Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob Agents Chemother 58:1707\u20131712","journal-title":"Antimicrob Agents Chemother"},{"key":"4123_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3349\/ymj.2016.57.3.641","volume":"57","author":"C Ahn","year":"2016","unstructured":"Ahn C, Yoon SS, Yong TS et al (2016) The resistance mechanism and clonal distribution of tigecycline-nonsusceptible Klebsiella pneumoniae isolates in Korea. Yonsei Med J 57:641\u2013646","journal-title":"Yonsei Med J"},{"key":"4123_CR13","doi-asserted-by":"publisher","first-page":"6151","DOI":"10.1128\/AAC.03053-14","volume":"58","author":"LE Nielsen","year":"2014","unstructured":"Nielsen LE, Snesrud EC, Onmus-Leone F et al (2014) IS5 element integration, a novel mechanism for rapid in vivo emergence of tigecycline nonsusceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother 58:6151\u20136156","journal-title":"Antimicrob Agents Chemother"},{"key":"4123_CR14","unstructured":"Clinical and Laboratory Standards Institute (2015) Verification of commercial microbial identification and antimicrobial susceptibility testing systems. 1st edn. CLSI guideline M52. Wayne, America"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04123-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-04123-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04123-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T10:18:30Z","timestamp":1621592310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-04123-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["4123"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-04123-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"6 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}